期刊
JOURNAL OF DERMATOLOGICAL SCIENCE
卷 53, 期 2, 页码 140-145出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.jdermsci.2008.08.017
关键词
Melanogenesis; Pyrroloquinoline quinone (PQQ); Tyrosinase; Tyrosinase-related protein (TRP); Microphthalmia-associated transcription factor (Mitf)
类别
Background: Increased production and accumulation of melanin leads to various hyperpigmentation disorders. Melanin synthesis is regulated by melanogenic proteins such as tyrosinase, tyrosinase-related protein (TRP)-1 and -2, and their transcription factors. Objective: In this study, we assessed the effects of PQQ on melanogenic protein expression of murine B16 melanoma cells. Methods: We assessed melanin production of PQQ-treated B16 melanoma cells. Furthermore, we investigated the effect of PQQ on the activity of melanogenic enzymes and their expression using Western blot and semi-quantitative RT-PCR analyses. Results: In the present study, PQQ inhibited melanin synthesis in cultured melanoma cells stimulated by either alpha-melanocyte stimulating hormone (alpha-MSH) or 3-isobutyl-1-methylxanthine (IBMX). To elucidate the mechanism of the effect of PQQ on melanogenesis, we performed Western blotting for melanogenic proteins, such as tyrosinase, TRP-1, and TRP-2. PQQ inhibited tyrosinase expression, however, it did not inhibit TRP-2 expression. Used as the stimulant for melanogenesis, both alpha-MSH and IBMX gave the same results for melanogenic protein expression. Semi-quantitative RT-PCR analysis showed that the depigmentation effect of PQQ might be due to the inhibition of tyrosinase gene transcription but not the inhibition of microphthalmia-associated transcription factor (Mitf). Conclusion: This report indicates that PQQ is a possible anti-melanogenic agent and might be effective against hyperpigmentation disorders. (C) 2008 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据